Mifepristone as Adjunctive Therapy in Alzheimer's Disease
Status:
Terminated
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of C-1073 (Mifepristone) on cognition in
patients with Alzheimer's disease (AD) who are also taking an acetylcholinesterase inhibitor
(Aricept, Exelon or Reminyl).